Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Jul 26, 2016

Total Value: $218M (100.0% shares, 0.0% debt)

Holdings (18)

ANIK ANIKA THERAPEUTICS INC 10.1%

Value $22.14M Shares 412,588 Est. Cost $38.50 Unrealized +22.4%

— GNC HLDGS INC 7.6%

Value $16.57M Shares 681,955 Est. Cost $30.08 Unrealized —

— AMAG PHARMACEUTICALS INC 7.4%

Value $16.06M Shares 671,585 Est. Cost $28.17 Unrealized —

SUPN SUPERNUS PHARMACEUTICALS INC 6.1%

Value $13.39M Shares 657,533 Est. Cost $17.80 Unrealized -0.3%

— TRIPLE-S MGMT CORP 6.0%

Value $13.02M Shares 532,876 Est. Cost $19.84 Unrealized —

MRK MERCK & CO INC 5.9%

Value $12.91M Shares 224,100 Est. Cost $36.03 Unrealized +9.6%

COR AMERISOURCEBERGEN CORP 5.8%

Value $12.69M Shares 160,000 Est. Cost $59.88 Unrealized 0.0%

— FEI CO 5.8%

Value $12.68M Shares 118,609 Est. Cost $82.13 Unrealized —

— TARO PHARMACEUTICAL INDS LTD 5.8%

Value $12.55M Shares 86,205 Est. Cost $143.25 Unrealized —

CAH CARDINAL HEALTH INC 5.7%

Value $12.48M Shares 160,000 Est. Cost $60.27 Unrealized 0.0%

CRL CHARLES RIV LABS INTL INC 5.7%

Value $12.33M Shares 149,612 Est. Cost $63.72 Unrealized +29.3%

ELV ANTHEM INC 5.7%

Value $12.33M Shares 93,900 Est. Cost $119.87 Unrealized +0.0%

— LIFEPOINT HEALTH INC 5.6%

Value $12.15M Shares 185,851 Est. Cost $67.19 Unrealized —

— CONCORDIA INTL CORP 5.4%

Value $11.7M Shares 543,000 Est. Cost $21.54 Unrealized —

— INC RESH HLDGS INC 5.0%

Value $10.91M Shares 286,270 Est. Cost $41.21 Unrealized —

— INSYS THERAPEUTICS INC NEW 4.7%

Value $10.2M Shares 788,175 Est. Cost $12.94 Unrealized —

OSUR ORASURE TECHNOLOGIES INC 1.3%

Value $2.812M Shares 475,771 Est. Cost $6.47 Unrealized +9.9%

ICCC IMMUCELL CORP 0.5%

Value $1.161M Shares 168,323 Est. Cost $5.29 Unrealized +27.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ANIK	ANIKA THERAPEUTICS INC	412,588	$22.14M	10.1%	$38.50	+22.4%	COM	035255108
—	GNC HLDGS INC	681,955	$16.57M	7.6%	$30.08	—	COM CL A	36191G107
—	AMAG PHARMACEUTICALS INC	671,585	$16.06M	7.4%	$28.17	—	COM	00163U106
SUPN	SUPERNUS PHARMACEUTICALS INC	657,533	$13.39M	6.1%	$17.80	-0.3%	COM	868459108
—	TRIPLE-S MGMT CORP	532,876	$13.02M	6.0%	$19.84	—	CL B	896749108
MRK	MERCK & CO INC	224,100	$12.91M	5.9%	$36.03	+9.6%	COM	58933Y105
COR	AMERISOURCEBERGEN CORP	160,000	$12.69M	5.8%	$59.88	0.0%	COM	03073E105
—	FEI CO	118,609	$12.68M	5.8%	$82.13	—	COM	30241L109
—	TARO PHARMACEUTICAL INDS LTD	86,205	$12.55M	5.8%	$143.25	—	SHS	M8737E108
CAH	CARDINAL HEALTH INC	160,000	$12.48M	5.7%	$60.27	0.0%	COM	14149Y108
CRL	CHARLES RIV LABS INTL INC	149,612	$12.33M	5.7%	$63.72	+29.3%	COM	159864107
ELV	ANTHEM INC	93,900	$12.33M	5.7%	$119.87	+0.0%	COM	036752103
—	LIFEPOINT HEALTH INC	185,851	$12.15M	5.6%	$67.19	—	COM	53219L109
—	CONCORDIA INTL CORP	543,000	$11.7M	5.4%	$21.54	—	COM	20653P102
—	INC RESH HLDGS INC	286,270	$10.91M	5.0%	$41.21	—	CL A	45329R109
—	INSYS THERAPEUTICS INC NEW	788,175	$10.2M	4.7%	$12.94	—	COM NEW	45824V209
OSUR	ORASURE TECHNOLOGIES INC	475,771	$2.812M	1.3%	$6.47	+9.9%	COM	68554V108
ICCC	IMMUCELL CORP	168,323	$1.161M	0.5%	$5.29	+27.6%	COM PAR $0.10	452525306